Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Cencora Inc COR

Healthcare
Cencora, Inc. is a global pharmaceutical sourcing and distribution services company. The Company is focused on improving the lives of people and animals around the world. It is engaged in the delivery of pharmaceuticals, healthcare products, and solutions. The Company operates through two segments: U.S. Healthcare Solutions and International Healthcare Solutions. The U.S. Healthcare Solutions... see more

Recent & Breaking News (NYSE:COR)

Cencora Announces Date and Time for Second Quarter Fiscal 2024 Earnings Release

Business Wire April 5, 2024

Cencora Announces Leadership Succession Plan

Business Wire March 12, 2024

Cencora Announces Common Share Repurchase From Walgreens Boots Alliance

Business Wire February 7, 2024

Walgreens Boots Alliance Sells Shares of Cencora For $992 Million of Proceeds

Business Wire February 7, 2024

Cencora Closes $500 Million Senior Notes Offering

Business Wire February 7, 2024

Cencora Prices $500 Million 5.125% Senior Notes Due 2034

Business Wire February 5, 2024

Cencora Reports Fiscal 2024 First Quarter Results

Business Wire January 31, 2024

Cencora Announces Date and Time for First Quarter Fiscal 2024 Earnings Release

Business Wire January 4, 2024

Sapphiros and Cencora, formerly AmerisourceBergen Corporation, Enter into Distribution Agreement

PR Newswire November 22, 2023

Cencora Announces Common Share Repurchase From Walgreens Boots Alliance

Business Wire November 9, 2023

Cencora Reports Fiscal 2023 Fourth Quarter and Year End Results

Business Wire November 2, 2023

Cencora, Formerly AmerisourceBergen, Announces Date and Time for Fourth Quarter Fiscal 2023 Earnings Release

Business Wire October 2, 2023

AmerisourceBergen Elects Werner Baumann and Lauren Tyler to Its Board of Directors

Business Wire August 15, 2023

AmerisourceBergen Announces Registered Public Offering of Common Shares and Common Share Repurchase

Business Wire August 3, 2023

AmerisourceBergen Reports Fiscal 2023 Third Quarter Results

Business Wire August 2, 2023

AmerisourceBergen Announces Date and Time for Third Quarter Fiscal 2023 Earnings Release

Business Wire June 29, 2023

TPG and AmerisourceBergen Announce Completion of Acquisition of OneOncology

Business Wire June 9, 2023

AmerisourceBergen Announces Common Share Repurchase From Walgreens Boots Alliance

Business Wire May 11, 2023

AmerisourceBergen Reports Fiscal 2023 Second Quarter Results

Business Wire May 2, 2023

AmerisourceBergen Launches Cell and Gene Therapy Innovation Hub

Business Wire April 24, 2023